Affiliation: Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Dr. Wenlei Jiang is a Senior Science Advisor at Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. FDA. Her research interests focus on bioequivalence standard development for generic complex drug products, global harmonization of generic drug approval criteria, and post-market surveillance of generic drugs. She currently serves as Chair at Product Quality Research Institute (PQRI) Steering Committee and co-Chair of International Pharmaceutical Regulatory Program (IPRP) Nanotechnology Working Group. She is also a member of National Cancer Institute (NCI) Nanotechnology Characterization Laboratory (NCL) Scientific Oversight Committee.